Abstract:The best hope for slowing the progression of Alzheimer's disease (AD) will necessitate identifying sensitive biomarkers that precede and predict future symptomatic onset, i.e., amnestic Mild Cognitive Impairment (aMCI). We previously developed surface multivariate tensor-based morphometry (mTBM) and grey matter morphology signatures as potential structural MRI AD biomarkers to study hippocampal and lateral ventricular morphology. We subsequently developed patch-based sparse coding algorithms to successfully extract the most discriminating features from MR images for predicting cognitive decline. We now use these methods on a sample balanced for APOE gene dose. From a prospective cohort study, 18 initially cognitively unimpaired adults who subsequently progressed to the clinical diagnosis of aMCI or dementia due to AD within 1.8±0.8 years (progressors) were matched for age, sex, education, and APOE4 gene dose to 20 adults who remained cognitively unimpaired for at least 4 years after baseline visits (nonprogressors). Each baseline MRI scan was segmented with FSL (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki), the hippocampal and ventricle surfaces parameterized, and the surface multivariate morphometry statistics (MMS) consisting of mTBM and radial distance (RD) generated. A collection of overlapping patches on the surface as the initial sparse coding dictionary was constructed. Stochastic Coordinate Coding was then applied to learn a dictionary and sparse codes. The max-pooling algorithm on the newly learned high-dimensional features was used to obtain a final set of low-dimensional features. Finally, an AdaBoost classifier was applied to categorize aMCI and cognitively unimpaired individuals with 5-fold cross validation adopted to evaluate classification accuracy, sensitivity, specificity, positive and negative predictive values. The prediction result of aMCI/AD was achieved with hippocampal surface MMS features, with 100% accuracy, 100% sensitivity, 100% specificity, 100% positive and 100% negative predictive values. This compares to 79% sensitivity and 78% specificity in the same sample based on standard automated brain mapping algorithmic programs to measure hippocampal volume, and assessed via binary logistic regression, and leave-one-out procedures. While our findings should be considered preliminary, sparse coding together with the surface multivariate morphometry may be applied to individual volumetric MRIs to predict imminent progression from the preclinical to clinical stages of AD with great accuracy.

Predicting Future Cognitive Decline with Hyperbolic Stochastic Coding

Hyperbolic Space Sparse Coding with Its Application on Prediction of Alzheimer's Disease in Mild Cognitive Impairment.

APPLYING SPARSE CODING TO SURFACE MULTIVARIATE TENSOR-BASED MORPHOMETRY TO PREDICT FUTURE COGNITIVE DECLINE.

A Novel Cascade Machine Learning Pipeline for Alzheimer’s Disease Identification and Prediction

IMPROVED PREDICTION OF PROGRESSION TO CLINICAL STAGES OF ALZHEIMER’S DISEASE USING MULTIVARIATE SURFACE MORPHOMETRY OF MRI BIOMARKERS AND PATCH-BASED SPARSE CODING

Improved Prediction of Imminent Progression to Clinically Significant Memory Decline Using Surface Multivariate Morphometry Statistics and Sparse Coding

An Improved Strategy for Predicting Alzheimer's Disease Progression in Patients with Mild Cognitive Impairment by Clustering Hippocampal Shape Data

Cognitive Function Assessment and Prediction for Subjective Cognitive Decline and Mild Cognitive Impairment.

Prediction of Clinical Scores for Subjective Cognitive Decline and Mild Cognitive Impairment.

PATCH-BASED SPARSE CODING AND MULTIVARIATE SURFACE MORPHOMETRY FOR PREDICTING AMNESTIC MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE IN COGNITIVELY UNIMPAIRED INDIVIDUALS

Multigroup Recognition of Dementia Patients with Dynamic Brain Connectivity under Multimodal Cortex Parcellation

Predicting Cognitive Declines Using Longitudinally Enriched Representations For Imaging Biomarkers

Dynamic Hyper-Graph Inference Framework for Computer-Assisted Diagnosis of Neurodegenerative Diseases

Evaluating the Predictive Power of Multivariate Tensor-based Morphometry in Alzheimers Disease Progression via Convex Fused Sparse Group Lasso.

Isometry Invariant Shape Descriptors for Abnormality Detection on Brain Surfaces Affected by Alzheimer’s Disease

Feature selective temporal prediction of Alzheimer's disease progression using hippocampus surface morphometry.

Improved Prediction of Amyloid-β and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding

Predicting Tau Accumulation in Cerebral Cortex with Multivariate MRI Morphometry Measurements, Sparse Coding, and Correntropy

Improved Prediction of Beta-Amyloid and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding

Integrating Static and Dynamic Data for Improved Prediction of Cognitive Declines Using Augmented Genotype-Phenotype Representations.

A Novel Dynamic Hyper-graph Inference Framework for Computer Assisted Diagnosis of Neuro-Diseases